Eli Lilly (LLY) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Eli Lilly And Company  (NYSE: LLY)
 

Eli Lilly Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Eli Lilly And's Inventory turnover ratio has remained unchanged compare to previous quarter at 0.96 in the first quarter 2026Average processing period, for Eli Lilly And's inventories remained unchanged at 380 days, in the Mar 31 2026 quarter.

Within Healthcare sector 319 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 419 in the fourth quarter 2025, to 452.

LLY Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Eli Lilly And Company Market Share?

What is Inventory Turnover Ratio?




LLY Inventory Turnover Ratio (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 56.04 % 81.1 % 63.28 % 69.93 % 52.59 %
Y / Y Cost of Sales Growth 60.82 % 40.27 % 38.58 % 12.79 % 32.91 %
Inventory Turnover Ratio (TTM) 0.96 0.96 1.01 1.05 1.16
LLY's Total Ranking # 452 # 419 # 446 # 1074 # 561
Average inventory processing period 379 382 363 349 314
Seq. Inventory Growth 5.71 % 12.84 % 10.59 % 18.29 % 22.69 %
Seq. Cost of Sales Growth 6.09 % 12.08 % 22.9 % 10.05 % -7.47 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 96
Healthcare Sector # 320
Overall Market # 452

Inventory Turnover Ratio Statistics
High Average Low
2.09 1.6 0.96
(June 30. 2012)   (Dec 31 2025)




Financial Statements
Eli Lilly And's Inventories $ 14,529 Millions Visit LLY's Balance sheet
Eli Lilly And's Cost of Revenues TTM $ 12,405 Millions Visit LLY's Income Statement
What are LLY's Sales? Visit LLY's Sales by Segment

Other Inventory Turnover Ratios
Eli Lilly And's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LLY's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LLY's Competitors
Inventory Turnover Ratio for LLY's Suppliers
Inventory Turnover Ratio for LLY's Customers

You may also want to know
LLY's Sales Growth Rates LLY's Pe Price to earnings ratio LLY's Receivables Turnover Ratio LLY's Stock Quote
LLY's Net Income Growth Rates LLY's Ps Price to Sales ratio LLY's Sales per Employee LLY's Asset Turnover Ratio
LLY's Net Margin LLY's Pb Price to Book ratio LLY's Financial Strength Ratios LLY's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Viatris Inc   2.34 $ 9,553.100  Millions$ 4,075  Millions
Perrigo Company Plc  2.34 $ 2,760.400  Millions$ 1,178  Millions
Caredx Inc   2.34 $ 64.029  Millions$ 27  Millions
Amgen Inc   2.33 $ 14,781.000  Millions$ 6,335  Millions
Angiodynamics Inc   2.32 $ 142.000  Millions$ 61  Millions
China Pharma Holdings Inc  2.29 $ 3.698  Millions$ 2  Millions
Cytosorbents Corporation  2.29 $ 10.000  Millions$ 4  Millions
Vivos Inc  2.27 $ 0.136  Millions$ 0  Millions
Beta Bionics Inc   2.26 $ 47.000  Millions$ 21  Millions
Resmed Inc   2.26 $ 2,094.000  Millions$ 928  Millions
Apyx Medical Corp  2.26 $ 20.000  Millions$ 9  Millions
Tela Bio Inc   2.25 $ 26.000  Millions$ 12  Millions
Eton Pharmaceuticals Inc   2.21 $ 39.000  Millions$ 18  Millions
Johnson and Johnson  2.20 $ 31,005.000  Millions$ 14,083  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  2.19 $ 11.133  Millions$ 5  Millions
Icu Medical Inc  2.18 $ 1,338.223  Millions$ 615  Millions
Zomedica Corp   2.18 $ 12.298  Millions$ 6  Millions
Medtronic Plc  2.17 $ 12,721.000  Millions$ 5,867  Millions
Bio techne Corp  2.17 $ 424.000  Millions$ 196  Millions
Repligen Corp  2.16 $ 359.567  Millions$ 166  Millions
Neuroone Medical Technologies Corp  2.15 $ 4.423  Millions$ 2  Millions
Embecta Corp   2.15 $ 398.000  Millions$ 185  Millions
Boston Scientific Corporation  2.15 $ 6,358.000  Millions$ 2,961  Millions
Ultragenyx Pharmaceutical Inc   2.15 $ 110.338  Millions$ 51  Millions
Yunhong Green Cti Ltd   2.14 $ 18.000  Millions$ 8  Millions
Inspiremd Inc   2.14 $ 7.000  Millions$ 3  Millions
Phibro Animal Health Corporation  2.13 $ 1,010.688  Millions$ 475  Millions
Accuray Incorporated  2.11 $ 313.685  Millions$ 149  Millions
Amphastar Pharmaceuticals Inc   2.09 $ 379.402  Millions$ 181  Millions
Axsome Therapeutics Inc   2.06 $ 52.414  Millions$ 25  Millions

Date modified: 2026-08-30T14:53:01+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.